课题基金 / 基金详情

项目摘要

项目成果

Ken Bruener的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/家长奖总结(不变)
英文摘要
Project Abstract/Summary of Parent Award (no change) The goal of this application is to deliver a brain MRI technology that feeds back head motion measurements derived from our Framewise Integrated Real-Time MRI Monitoring (FIRMM) to MRI scan participants in order to reduce head motion via behavioral training. Because MRI scanning produces high-resolution images and does not expose patients to radiation, it has become an immensely valuable diagnostic tool, particularly for imaging the brain. Last year, in the United States alone, there were over 8 million brain MRIs, costing an estimated $20-30 billion. Unfortunately, brain MRIs are limited by the fact that head motion during the scan can cause the resulting images to be suboptimal or even unusable. An estimated 20% of all brain MRIs are ruined by motion, wasting $2-4 billion annually. Currently, there are two predominant strategies to combat head motion: repeat scanning and anesthesia, both of which are inadequate. Repeat scanning, which consists of acquiring extra images (to ensure enough usable ones were acquired), increases scanning time and cost, and can result in too few usable images or unnecessary extra images. Anesthesia, which is given to patients who are likely to move (such as young children), presents a serious safety risk and is sometimes administered unnecessarily (i.e. the patient could hold still without anesthesia). Anesthesia is never an option for functional MRI (fMRI), which requires participants to be awake. The software-based FIRMM-biofeedback solution proposed in this grant uses MR images (as they are being collected) to compute a patient’s head motion in real time during an MRI scan. The availability of real time motion information will enable more informed anesthesia use and reduce excess scanning, making these methods safer and more efficient. Armed with real time motion information, scan operators will know exactly how many usable images have been acquired, preventing the acquisition of too many or too few extra images. Additionally, providing physicians with quantitative information about patient motion will allow them to make an informed decision regarding anesthesia, preventing unnecessary sedation. The proposed solution focuses on a completely new biobehavioral method for combating head motion: subject biofeedback. The technology can translate the head motion information into age-appropriate, visual biofeedback for the scan participant. By providing feedback to patients and research subjects, the FIRMM-biofeedback technology helps both pediatric and adult patients remain more still, improving image quality. The proposed research focuses on delivering proof-of-concept for FIRMM- biofeedback (Phase I) and building and validating a product version of FIRMM-biofeedback (Phase II). The FIRMM-biofeedback technology provides patients and research subjects with real time head motion information, with the goal of making MR scans safer, faster, more enjoyable and less expensive.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Framewise Integrated Real-Time MRI Monitoring (FIRMM) software commercialization readiness for clinical care
  • 批准号:
    10697965
  • 项目类别:
  • 资助金额:
    $106.28万
  • 财政年份:
    2023
  • 负责人:
    Ken Bruener
  • 依托单位:
Behavioral feedback and rewards for improving functional brain mapping in presurgical pediatric patients
  • 批准号:
    10546990
  • 项目类别:
  • 资助金额:
    $49.98万
  • 财政年份:
    2022
  • 负责人:
    Ken Bruener
  • 依托单位:
Behavioral feedback and rewards for improving functional brain mapping in presurgical pediatric patients
  • 批准号:
    10707227
  • 项目类别:
  • 资助金额:
    $19.88万
  • 财政年份:
    2022
  • 负责人:
    Ken Bruener
  • 依托单位:
Commercialization readiness of visual biofeedback to reduce head motion during MRI scans
  • 批准号:
    10382713
  • 项目类别:
  • 资助金额:
    $113.69万
  • 财政年份:
    2021
  • 负责人:
    Ken Bruener
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: